Get help and support on the ENA

Recommended courses

Courses at the EBI

 

14-17 October 2013
Next Generation Sequencing Workshop
EBI-EMBL, Hinxton, UK

29-31 October 2013
ESGI Workshop
EBI-EMBL, Hinxton, UK

18-19 November 2013
ENA Facilities Day
EBI-EMBL, Hinxton, UK

Support

References

Cochrane, G. et al. (2013) Facing Growth in the European Nucleotide Archive. Nucl. Acids Res. Database Issue.

Nakamura, Y., Cochrane, G. and Karsch-Mizrachi, I. (on behalf of the International Nucleotide Sequence Database Collaboration). (2013) The International Nucleotide Sequence Database Collaboration. Nucl. Acids Res. Database Issue

Amid, C. et al. (2012) Major submissions tool developments at the European Nucleotide Archive. Nucl. Acids Res. Database Issue.

Kodama, Y., Shumway, M., and Leinonen, R. (on behalf of the International Nucleotide Sequence Database Collaboration). (2012) The sequence read archive: explosive growth of sequencing data. Nucl. Acids Res. Database Issue

Karsch-Mizrachi, I., Nakamura, Y. and Cochrane, G. (on behalf of the International Nucleotide Sequence Database Collaboration). (2012) The International Nucleotide Sequence Database Collaboration. Nucl. Acids Res. Database Issue

Collaborators

The ENA achieves comprehensive coverage through partnership with other global bioinformatics service providers: the National Center for Biotechnology Information (NCBI) in the US and the DNA Data Bank of Japan (DDBJ). These three partners form the International Nucleotide Sequence Database Collaboration (INSDC), which has been underway for over a quarter of a century and now serves as a model for data sharing in the life sciences. Each of the three groups collects a proportion of the total sequence data reported worldwide, and all new and updated database entries are exchanged between the groups on a regular basis.

Principles of the INSDC include the provision of free and unrestricted access to data for all users and the maintenance of permanently accessible records.

Funding

ENA is developed and operated under the support of the European Molecular Biology Laboratory (EMBL) and through grants from external bodies that include the Seventh Framework Programme of the European Commission (EC-FP7), the British Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust (WT)